Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease
worldwide. With no Food and Drug Administration approved drugs, current treatment options …

Among various factors, such as an unhealthy diet or a sedentarity lifestyle, excessive
fructose consumption is known to favor nonalcoholic fatty liver disease (NAFLD), as fructose …

Background & Aims Nonalcoholic fatty liver disease (NAFLD) is associated with increased
risk of hepatic, cardiovascular, and metabolic diseases. High-protein diets, rich in …

Abstract Purpose of Review Reduction of serum low-density lipoprotein cholesterol (LDL-C)
levels by statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is continuing to rise in many
countries, paralleling the epidemic of obesity worldwide. In the last years, the concept of …

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of pathologies ranging
from uncomplicated hepatic fat accumulation to a state of lobular inflammation and …

The fibroblast growth factor (FGF) family is composed of 18 secreted signaling proteins
consisting of canonical FGFs and endocrine FGFs that activate four receptor tyrosine …

Lactobacillus paracasei FZU103, a probiotic previously isolated from the traditional brewing
process of Hongqu rice wine, may have the beneficial effect of improving the disorder of lipid …

Hypothyroidism is often associated with elevated serum levels of total cholesterol, LDL-C
and triglycerides. Thyroid hormone (TH) affects the production, clearance and transformation …

Background Overconsumption of dietary sugars, fructose in particular, is linked to
cardiovascular risk factors such as type 2 diabetes, obesity, dyslipidemia and nonalcoholic …